<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338970</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Platelet Aggregation Alterations in Patients with Severe Viral Infection Treated at the Intensive Care Unit: Implications for Mortality Risk.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">778</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13090778</ELocationID><Abstract><AbstractText>Severe viral infections often result in abnormal platelet function, affecting various stages of hemostasis. Activated platelets are often considered prothrombotic and more susceptible to further stimulation. However, emerging evidence suggests that initial hyperactivation is followed by platelet exhaustion and hypo-responsiveness, affecting platelet degranulation, activation, and aggregation. We examined early alterations in platelet aggregation among patients (N = 28) with acute respiratory distress syndrome and SARS-CoV-2 infection who were receiving mechanical ventilation and venovenous extracorporeal membrane oxygenation support. Blood samples were stimulated with four different activators: arachidonic acid, adenosine diphosphate, thrombin receptor-activating protein 6, and ristocetin. Our observations revealed that platelet aggregation was reduced in most patients upon admission (ranging from 61 to 89%, depending on the agonist used), and this trend intensified during the 5-day observation period. Concurrently, other coagulation parameters remained within normal ranges, except for elevated d-dimer and fibrinogen levels. Importantly, we found a significant association between platelet aggregation and patient mortality. Impaired platelet aggregation was more severe in patients who ultimately died, and reduced aggregation was associated with a significantly lower probability of survival, as confirmed by Kaplan-Meier analysis (<i>p</i> = 0.028). These findings underscore the potential of aggregometry as an early detection tool for identifying patients at higher risk of mortality within this specific cohort.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bakowski</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smiechowicz</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2649-0541</Identifier><AffiliationInfo><Affiliation>Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dragan</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goździk</LastName><ForeName>Waldemar</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamik</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0541-841X</Identifier><AffiliationInfo><Affiliation>Clinical Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SUBK.A170.23.033</GrantID><Agency>Wroclaw Medical University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">platelet aggregation</Keyword><Keyword MajorTopicYN="N">platelet desensitization</Keyword><Keyword MajorTopicYN="N">viral sepsis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338970</ArticleId><ArticleId IdType="pmc">PMC11435101</ArticleId><ArticleId IdType="doi">10.3390/pathogens13090778</ArticleId><ArticleId IdType="pii">pathogens13090778</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Stoppelaar S.F., van’t Veer C., van der Poll T. The role of platelets in sepsis. Thromb. Haemost. 2014;112:666–677. doi: 10.1160/TH14-02-0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-02-0126</ArticleId><ArticleId IdType="pubmed">24966015</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinov R.I., Evtugina N.G., Peshkova A.D., Safiullina S.I., Andrianova I.A., Khabirova A.I., Nagaswami C., Khismatullin R.R., Sannikova S.S., Weisel J.W. Altered platelet and coagulation function in moderate-to-severe COVID-19. Sci. Rep. 2021;11:16290. doi: 10.1038/s41598-021-95397-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95397-6</ArticleId><ArticleId IdType="pmc">PMC8357814</ArticleId><ArticleId IdType="pubmed">34381066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciaudone A., Corkrey H., Humphries F., Koupenova M. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond. Circ. Res. 2023;132:1272–1289. doi: 10.1161/CIRCRESAHA.122.321930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321930</ArticleId><ArticleId IdType="pmc">PMC10171305</ArticleId><ArticleId IdType="pubmed">37167360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A.C., Knight R., Walker V., Ip S., Cooper J.A., Bolton T., Keene S., Denholm R., Akbari A., Abbasizanjani H., et al. Circulation Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation. 2022;146:892–906. doi: 10.1161/CIRCULATIONAHA.122.060785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060785</ArticleId><ArticleId IdType="pmc">PMC9484653</ArticleId><ArticleId IdType="pubmed">36121907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanth Manne B., Denorme F., Middleton E.A., Portier I., Rowley J.W., Stubben C., Petrey A.C., Tolley N.D., Guo L., Cody M., et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136:1317–1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruberto F., Chistolini A., Curreli M., Frati G., Marullo A.G.M., Biondi-Zoccai G., Mancone M., Sciarretta S., Miraldi F., Alessandri F., et al. Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: Another COVID-19 paradox? J. Thromb. Thrombolysis. 2021;52:105–110. doi: 10.1007/s11239-020-02339-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02339-6</ArticleId><ArticleId IdType="pmc">PMC7778414</ArticleId><ArticleId IdType="pubmed">33387210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongiovanni D., Klug M., Lazareva O., Weidlich S., Biasi M., Ursu S., Warth S., Buske C., Lukas M., Spinner C.D., et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis. 2021;12:50. doi: 10.1038/s41419-020-03333-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03333-9</ArticleId><ArticleId IdType="pmc">PMC7790351</ArticleId><ArticleId IdType="pubmed">33414384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertini P., Guarracino F., Falcone M., Nardelli P., Landoni G., Nocci M., Paternoster G. ECMO in COVID-19 Patients: A Systematic Review and Meta-analysis. J. Cardiothorac. Vasc. Anesth. 2022;36:2700–2706. doi: 10.1053/j.jvca.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8585556</ArticleId><ArticleId IdType="pubmed">34906383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Zhang Y., Liu J., Zhou Z. Thrombosis and bleeding in patients with COVID-19 requiring extracorporeal membrane oxygenation: A systematic review and meta-analysis. Res. Pract. Thromb. Haemost. 2023;7:100103. doi: 10.1016/j.rpth.2023.100103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rpth.2023.100103</ArticleId><ArticleId IdType="pmc">PMC9993729</ArticleId><ArticleId IdType="pubmed">36999123</ArticleId></ArticleIdList></Reference><Reference><Citation>Reininger A.J., Heijnen H.F.G., Schumann H., Specht H.M., Schramm W., Ruggeri Z.M. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood. 2006;107:3537–3545. doi: 10.1182/blood-2005-02-0618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-02-0618</ArticleId><ArticleId IdType="pmc">PMC1895770</ArticleId><ArticleId IdType="pubmed">16449527</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves I., Nesbitt W.S., Yuan Y., Jackson S.P. Importance of temporal flow gradients and integrin alphaIIbbeta3 mechanotransduction for shear activation of platelets. J. Biol. Chem. 2005;280:15430–15437. doi: 10.1074/jbc.M410235200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410235200</ArticleId><ArticleId IdType="pubmed">15701653</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S., Tamura N., Li M., Handa M., Ikeda Y., Handa S., Ruggri Z.M. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J. Thromb. Haemost. 2003;1:2022–2030. doi: 10.1046/j.1538-7836.2003.00349.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1538-7836.2003.00349.x</ArticleId><ArticleId IdType="pubmed">12941046</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Mondal N.K., Zheng S., Koenig S.C., Slaughter M.S., Griffith B.P., Wu Z.J. High Shear Induces Platelet Dysfunction Leading to Enhanced Thrombotic Propensity and Diminished Hemostatic Capacity. Platelets. 2019;30:112. doi: 10.1080/09537104.2017.1384542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2017.1384542</ArticleId><ArticleId IdType="pmc">PMC6108946</ArticleId><ArticleId IdType="pubmed">29182470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Mondal N.K., Ding J., Gao J., Griffith B.P., Wu Z.J. Shear-induced platelet receptor shedding by non-physiological high shear stress with short exposure time: Glycoprotein Ibα and glycoprotein VI. Thromb. Res. 2015;135:692. doi: 10.1016/j.thromres.2015.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.01.030</ArticleId><ArticleId IdType="pmc">PMC4361313</ArticleId><ArticleId IdType="pubmed">25677981</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526–2533. doi: 10.1001/JAMA.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A., Evans L.E., Alhazzani W., Levy M.M., Antonelli M., Ferrer R., Kumar A., Sevransky J.E., Sprung C.L., Nunnally M.E., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304–377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekar K., Badulak J., Peek G., Boeken U., Dalton H.J., Arora L., Zakhary B., Ramanathan K., Starr J., Akkanti B., et al. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020;66:707–721. doi: 10.1097/MAT.0000000000001193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001193</ArticleId><ArticleId IdType="pmc">PMC7228451</ArticleId><ArticleId IdType="pubmed">32604322</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L., Aubron C., Brochard L., Chiche J.D., Combes A., Dreyfuss D., Forel J.M., Guérin C., Jaber S., Mekontso-Dessap A., et al. Formal guidelines: Management of acute respiratory distress syndrome. Ann. Intensive Care. 2019;9:69. doi: 10.1186/s13613-019-0540-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0540-9</ArticleId><ArticleId IdType="pmc">PMC6565761</ArticleId><ArticleId IdType="pubmed">31197492</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfes V., Ribeiro L.S., Hawwari I., Böttcher L., Rosero N., Maasewerd S., Santos M.L.S., Próchnicki T., Silva C.M.d.S., Wanderley C.W.d.S., et al. Platelets Fuel the Inflammasome Activation of Innate Immune Cells. Cell Rep. 2020;31:107615. doi: 10.1016/j.celrep.2020.107615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107615</ArticleId><ArticleId IdType="pmc">PMC7225754</ArticleId><ArticleId IdType="pubmed">32402278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognasse F., Nguyen K.A., Damien P., McNicol A., Pozzetto B., Hamzeh-Cognasse H., Garraud O. The inflammatory role of platelets via their TLRs and Siglec receptors. Front. Immunol. 2015;6:129756. doi: 10.3389/fimmu.2015.00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00083</ArticleId><ArticleId IdType="pmc">PMC4345914</ArticleId><ArticleId IdType="pubmed">25784910</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T.J., Bilaloglu S., Cornwell M., Burgess H.M., Virginio V.W., Drenkova K., Ibrahim H., Yuriditsky E., Aphinyanaphongs Y., Lifshitz M., et al. Platelets contribute to disease severity in COVID-19. J. Thromb. Haemost. 2021;19:3139–3153. doi: 10.1111/jth.15534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15534</ArticleId><ArticleId IdType="pmc">PMC8646651</ArticleId><ArticleId IdType="pubmed">34538015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Yuan H., Wu Y.L., Fu S., Pan X.Y. The Predictive Value of Heparin-Binding Protein and D-Dimer in Patients with Sepsis. Int. J. Gen. Med. 2023;16:2295–2303. doi: 10.2147/IJGM.S409328.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S409328</ArticleId><ArticleId IdType="pmc">PMC10257474</ArticleId><ArticleId IdType="pubmed">37304904</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Pan Y., Xu C., Li D. Characteristics of emergency patients with markedly elevated D-dimer levels. Sci. Rep. 2020;10:7784. doi: 10.1038/s41598-020-64853-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64853-0</ArticleId><ArticleId IdType="pmc">PMC7210267</ArticleId><ArticleId IdType="pubmed">32385325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder M., Baldus N., Stallmann D., Jeserich M., Goller I., Wirth L., Pollmeier L., Hofmann M., Bode C., Busch H.J., et al. Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function. Res. Pract. Thromb. Haemost. 2023;7:100025. doi: 10.1016/j.rpth.2022.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rpth.2022.100025</ArticleId><ArticleId IdType="pmc">PMC9783187</ArticleId><ArticleId IdType="pubmed">36575689</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolin A.J., Dalçóquio T.F., Salsoso R., Remo R.H., Kalil-Filho R., Hajjar L.A., Siciliano R.F., Kallás E.G., Baracioli L.M., Lima F.G., et al. Platelet Reactivity and Coagulation Markers in Patients with COVID-19. Adv. Ther. 2021;38:3911–3923. doi: 10.1007/s12325-021-01803-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-021-01803-w</ArticleId><ArticleId IdType="pmc">PMC8176448</ArticleId><ArticleId IdType="pubmed">34086266</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz C., Miesbach W., Herrmann E., Sonntagbauer M., Raimann F.J., Zacharowski K., Weber C.F., Adam E.H. Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients. Anesthesiology. 2021;134:457–467. doi: 10.1097/ALN.0000000000003685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003685</ArticleId><ArticleId IdType="pmc">PMC7864605</ArticleId><ArticleId IdType="pubmed">33417674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipińska-Gediga M., Lemańska-Perek A., Gozdzik W., Adamik B. Changes in plasma endocan level are related to circulatory but not respiratory failure in critically ill patients with COVID-19. Sci. Rep. 2023;13:22307. doi: 10.1038/s41598-023-48912-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48912-w</ArticleId><ArticleId IdType="pmc">PMC10724176</ArticleId><ArticleId IdType="pubmed">38102316</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poll T., Parker R.I. Platelet Activation and Endothelial Cell Dysfunction. Crit. Care Clin. 2020;36:233–253. doi: 10.1016/j.ccc.2019.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.11.002</ArticleId><ArticleId IdType="pubmed">32172811</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies G.R., Mills G.M., Lawrence M., Battle C., Morris K., Hawkins K., Williams P.R., Davidson S., Thomas D., Evans P.A. The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS ONE. 2014;9:e108589. doi: 10.1371/journal.pone.0108589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108589</ArticleId><ArticleId IdType="pmc">PMC4182491</ArticleId><ArticleId IdType="pubmed">25269018</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen M.A., Larsen J.B., Larsen K.M., Hvas A.M. Platelet function in patients with septic shock. Thromb. Res. 2020;185:33–42. doi: 10.1016/j.thromres.2019.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.11.011</ArticleId><ArticleId IdType="pubmed">31756573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S.X., Tyagi T., Jain K., Gu V.W., Lee S.H., Hwa J.M., Kwan J.M., Krause D.S., Lee A.I., Halene S., et al. Thrombocytopathy and endotheliopathy: Crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 2021;18:194–209. doi: 10.1038/s41569-020-00469-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00469-1</ArticleId><ArticleId IdType="pmc">PMC7675396</ArticleId><ArticleId IdType="pubmed">33214651</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M., Corkrey H.A., Vitseva O., Tanriverdi K., Somasundaran M., Liu P., Soofi S., Bhandari R., Godwin M., Parsi K.M., et al. SARS-CoV-2 Initiates Programmed Cell Death in Platelets. Circ. Res. 2021;129:631–646. doi: 10.1161/CIRCRESAHA.121.319117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319117</ArticleId><ArticleId IdType="pmc">PMC8409903</ArticleId><ArticleId IdType="pubmed">34293929</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia C., Duong J.A., Po M., Ribes A., Payre B., Mémier V., Sié P., Minville V., Voisin S., Payrastre B., et al. Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19. Blood Adv. 2022;6:3884–3898. doi: 10.1182/bloodadvances.2022007143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2022007143</ArticleId><ArticleId IdType="pmc">PMC9068266</ArticleId><ArticleId IdType="pubmed">35789374</ArticleId></ArticleIdList></Reference><Reference><Citation>Maquet J., Lafaurie M., Sommet A., Moulis G. Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19. Br. J. Haematol. 2020;190:e276–e279. doi: 10.1111/bjh.16950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16950</ArticleId><ArticleId IdType="pmc">PMC7323390</ArticleId><ArticleId IdType="pubmed">32557535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., Limami Y., Zaid N., Sadki K., Ben El Haj R., et al. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ. Res. 2020;127:1404–1418. doi: 10.1161/CIRCRESAHA.120.317703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark C.C., Jukema B.N., Barendrecht A.D., Spanjaard J.S., Jorritsma N.K.N., Smits S., de Maat S., Seinen C.W., Verhoef S., Parr N.M.J., et al. Thrombotic Events in COVID-19 Are Associated with a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity. Front. Med. 2021;8:650129. doi: 10.3389/fmed.2021.650129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.650129</ArticleId><ArticleId IdType="pmc">PMC8100661</ArticleId><ArticleId IdType="pubmed">33968958</ArticleId></ArticleIdList></Reference><Reference><Citation>Fälker K., Haglund L., Gunnarsson P., Nylander M., Lindahl T.L., Grenegård M. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. Biochem. J. 2011;436:469–480. doi: 10.1042/BJ20101360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20101360</ArticleId><ArticleId IdType="pubmed">21391917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauber H., Streif W., Fritz J., Ott H., Weigel G., Loacker L., Heinz A., Velik-Salchner C. Predicting Transfusion Requirements During Extracorporeal Membrane Oxygenation. J. Cardiothorac. Vasc. Anesth. 2016;30:692–701. doi: 10.1053/j.jvca.2016.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2016.01.009</ArticleId><ArticleId IdType="pubmed">27321792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P., Hoechter D.J., Buscher H., Venkatesh K., Whittam S., Joseph J., Jansz P. Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry. J. Cardiothorac. Vasc. Anesth. 2015;29:288–296. doi: 10.1053/j.jvca.2014.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2014.06.006</ArticleId><ArticleId IdType="pubmed">25655210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalbhenn J., Glonnegger H., Büchsel M., Priebe H.J., Zieger B. Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study. Crit. Care Med. 2022;50:1246–1255. doi: 10.1097/CCM.0000000000005467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005467</ArticleId><ArticleId IdType="pmc">PMC9275806</ArticleId><ArticleId IdType="pubmed">35234414</ArticleId></ArticleIdList></Reference><Reference><Citation>Balle C.M., Jeppesen A.N., Christensen S., Hvas A.M. Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients: A Systematic Review. Front. Cardiovasc. Med. 2018;5:157. doi: 10.3389/fcvm.2018.00157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00157</ArticleId><ArticleId IdType="pmc">PMC6237979</ArticleId><ArticleId IdType="pubmed">30474031</ArticleId></ArticleIdList></Reference><Reference><Citation>Balle C.M., Jeppesen A.N., Christensen S., Hvas A.M. Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients. Front. Cardiovasc. Med. 2019;6:114. doi: 10.3389/fcvm.2019.00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2019.00114</ArticleId><ArticleId IdType="pmc">PMC6694790</ArticleId><ArticleId IdType="pubmed">31440518</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuts S., Makhoul M., Mansouri A.N., Taccone F.S., Obeid A., Belliato M., Broman L.M., Malfertheiner M., Meani P., Raffa G.M., et al. Defining and understanding the “extra-corporeal membrane oxygenation gap” in the veno-venous configuration: Timing and causes of death. Artif. Organs. 2022;46:349–361. doi: 10.1111/aor.14058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.14058</ArticleId><ArticleId IdType="pmc">PMC9293076</ArticleId><ArticleId IdType="pubmed">34494291</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeibi Shirejini S., Carberry J., McQuilten Z.K., Burrell A.J.C., Gregory S.D., Hagemeyer C.E. Current and future strategies to monitor and manage coagulation in ECMO patients. Thromb. J. 2023;21:11. doi: 10.1186/s12959-023-00452-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-023-00452-z</ArticleId><ArticleId IdType="pmc">PMC9878987</ArticleId><ArticleId IdType="pubmed">36703184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>